Arrowhead Pharmaceuticals Inc.. (ARWR) NASDAQ
$22.61 0.08 (0.36%)
Market Cap: $2.79B
As of 04/18/24 04:00 PM EDT. Market closed.
Arrowhead Pharmaceuticals Inc.. (ARWR)
NASDAQ
$22.61
0.08 (0.36%)
Market Cap: $2.79B
As of 04/18/24 04:00 PM EDT. Market closed.
arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a ... read more
arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. our rnai-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. our targeted rnai molecule (trimtm) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. the trim platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hamilton James C | Chief Discovery/Trans Medicine | Apr 01, 2024 | Sale | $28.03 | 6,000 | 168,180 | 204,851 | Apr 03, 2024, 06:05 PM |
Lu Hongbo | Director | Mar 20, 2024 | Buy | $27.50 | 1,000 | 27,500 | 33,680 | Mar 20, 2024, 07:06 PM |
Lu Hongbo | Director | Mar 19, 2024 | Buy | $28.00 | 1,000 | 28,000 | 32,680 | Mar 20, 2024, 07:06 PM |
Lu Hongbo | Director | Mar 18, 2024 | Buy | $27.49 | 1,000 | 27,490 | 31,680 | Mar 20, 2024, 07:06 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Mar 06, 2024 | Sale | $35.19 | 40,000 | 1,407,600 | 400,600 | Mar 08, 2024, 05:54 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jan 31, 2024 | Option Exercise | $14.54 | 57,499 | 836,035 | 3,772,547 | Feb 02, 2024, 05:25 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jan 31, 2024 | Sale | $32.35 | 57,499 | 1,860,019 | 3,734,778 | Feb 02, 2024, 05:25 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jan 12, 2024 | Sale | $36.89 | 7,940 | 292,904 | 214,553 | Jan 17, 2024, 06:32 PM |
GIVEN DOUGLAS B | Director | Jan 11, 2024 | Sale | $38.06 | 2,911 | 110,788 | 130,811 | Jan 16, 2024, 06:06 PM |
Waddill William D. | Director | Jan 11, 2024 | Sale | $38.07 | 3,934 | 149,759 | 49,170 | Jan 16, 2024, 06:06 PM |
Ferrari Mauro | Director | Jan 11, 2024 | Sale | $38.06 | 3,147 | 119,787 | 61,778 | Jan 16, 2024, 06:06 PM |
Vakiener Victoria | Director | Jan 11, 2024 | Sale | $38.10 | 4,720 | 179,813 | 33,101 | Jan 16, 2024, 06:06 PM |
Oliver Tracie | Chief Commercial Officer | Jan 05, 2024 | Sale | $33.89 | 74 | 2,508 | 136,501 | Jan 08, 2024, 05:17 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 05, 2024 | Sale | $35.27 | 16,104 | 567,910 | 455,304 | Jan 08, 2024, 05:16 PM |
San Martin Javier | Chief Medical Officer | Jan 05, 2024 | Sale | $35.26 | 8,303 | 292,804 | 206,000 | Jan 08, 2024, 05:16 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jan 05, 2024 | Sale | $35.18 | 32,143 | 1,130,748 | 249,134 | Jan 05, 2024, 08:02 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jan 03, 2024 | Sale | $32.19 | 6,300 | 202,781 | 178,734 | Jan 05, 2024, 08:02 PM |
O'Brien Patrick | COO and General Counsel | Jan 03, 2024 | Sale | $32.28 | 8,749 | 282,439 | 408,726 | Jan 05, 2024, 07:58 PM |
O'Brien Patrick | COO and General Counsel | Jan 05, 2024 | Sale | $35.27 | 22,841 | 805,716 | 485,326 | Jan 05, 2024, 07:58 PM |
O'Brien Patrick | COO and General Counsel | Jan 04, 2024 | Sale | $32.63 | 1,600 | 52,208 | 402,226 | Jan 05, 2024, 07:58 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jan 02, 2024 | Sale | $31.01 | 9,952 | 308,637 | 3,720,366 | Jan 04, 2024, 05:25 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 20, 2023 | Sale | $28.54 | 12,000 | 342,480 | 3,725,000 | Dec 22, 2023, 05:04 PM |
Ferrari Mauro | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 65,825 | Dec 19, 2023, 04:03 PM |
PERRY MICHAEL S | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 114,754 | Dec 19, 2023, 03:55 PM |
OLUKOTUN ADEOYE Y | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 22,854 | Dec 19, 2023, 03:54 PM |
Vakiener Victoria | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 36,721 | Dec 19, 2023, 03:52 PM |
GIVEN DOUGLAS B | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 132,622 | Dec 19, 2023, 03:51 PM |
Waddill William D. | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 51,804 | Dec 19, 2023, 03:41 PM |
San Martin Javier | Chief Medical Officer | Nov 20, 2023 | Sale | $28.80 | 19,700 | 567,315 | 136,742 | Nov 22, 2023, 02:31 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 25, 2023 | Sale | $24.21 | 24,338 | 589,223 | 3,737,000 | Oct 27, 2023, 06:23 PM |
Vakiener Victoria | Director | Sep 28, 2023 | Sale | $26.33 | 1,550 | 40,811 | 21,734 | Oct 02, 2023, 05:51 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 18, 2023 | Option Exercise | $4.75 | 57,755 | 274,336 | 3,819,093 | Sep 20, 2023, 06:10 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 18, 2023 | Sale | $28.12 | 57,755 | 1,624,223 | 3,787,570 | Sep 20, 2023, 06:10 PM |
Oliver Tracie | Chief Commercial Officer | Jul 03, 2023 | Sale | $35.31 | 8,925 | 315,142 | 61,575 | Jul 06, 2023, 06:04 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jun 30, 2023 | Sale | $35.53 | 3,000 | 106,590 | 188,484 | Jul 05, 2023, 06:15 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jun 27, 2023 | Sale | $36.20 | 15,000 | 543,000 | 381,704 | Jun 29, 2023, 06:41 PM |
GIVEN DOUGLAS B | Director | May 05, 2023 | Sale | $40.90 | 6,500 | 265,850 | 117,635 | May 08, 2023, 06:29 PM |
Anzalone Christopher Richard | Chief Executive Officer | May 03, 2023 | Option Exercise | $2.01 | 54,928 | 110,405 | 3,816,266 | May 05, 2023, 07:04 PM |
Anzalone Christopher Richard | Chief Executive Officer | May 04, 2023 | Option Exercise | $2.01 | 50,000 | 100,500 | 3,811,338 | May 05, 2023, 07:04 PM |
Anzalone Christopher Richard | Chief Executive Officer | May 03, 2023 | Sale | $39.14 | 54,928 | 2,149,882 | 3,761,338 | May 05, 2023, 07:04 PM |
Anzalone Christopher Richard | Chief Executive Officer | May 04, 2023 | Sale | $39.52 | 50,000 | 1,975,792 | 3,787,330 | May 05, 2023, 07:04 PM |
OLUKOTUN ADEOYE Y | Director | Mar 03, 2023 | Sale | $32.65 | 11,350 | 370,578 | 7,867 | Mar 06, 2023, 06:04 PM |
GIVEN DOUGLAS B | Director | Feb 27, 2023 | Sale | $32.62 | 875 | 28,542 | 13,000 | Mar 01, 2023, 06:14 PM |
Waddill William D. | Director | Jan 09, 2023 | Sale | $30.00 | 3,200 | 96,000 | 28,950 | Jan 11, 2023, 08:23 PM |
O'Brien Patrick | COO and General Counsel | Jan 05, 2023 | Sale | $37.39 | 15,000 | 560,850 | 420,875 | Jan 06, 2023, 07:30 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jan 05, 2023 | Sale | $37.40 | 13,803 | 516,232 | 198,057 | Jan 06, 2023, 07:24 PM |
O'Brien Patrick | COO and General Counsel | Jan 03, 2023 | Sale | $38.33 | 17,500 | 670,802 | 378,222 | Jan 05, 2023, 07:10 PM |
Hamilton James C | Chief Discovery/Trans Medicine | Jan 03, 2023 | Sale | $38.38 | 10,338 | 396,738 | 154,431 | Jan 05, 2023, 07:05 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Dec 29, 2022 | Sale | $40.00 | 30,625 | 1,225,000 | 336,704 | Dec 30, 2022, 05:12 PM |
O'Brien Patrick | General Counsel | Dec 21, 2022 | Option Exercise | $6.15 | 32,000 | 196,800 | 380,875 | Dec 22, 2022, 08:01 PM |
San Martin Javier | Chief Medical Officer | Nov 21, 2022 | Sale | $29.99 | 19,500 | 584,738 | 91,700 | Nov 22, 2022, 06:05 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 27, 2022 | Option Exercise | $30.79 | 40,624 | 1,250,679 | 3,469,856 | Sep 29, 2022, 05:15 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $14.54 | 2,501 | 36,365 | 4,060,135 | Jul 11, 2022, 08:08 PM |
Anzalone Christopher Richard | Chief Executive Officer | Feb 11, 2022 | Option Exercise | $5.19 | 146,388 | 759,754 | 4,204,022 | Feb 14, 2022, 08:54 AM |
Anzalone Christopher Richard | Chief Executive Officer | Feb 11, 2022 | Sale | $51.91 | 146,388 | 7,598,865 | 4,163,169 | Feb 14, 2022, 08:54 AM |
Anzalone Christopher Richard | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $5.19 | 11,806 | 61,273 | 4,057,634 | Jan 07, 2022, 09:39 PM |
O'Brien Patrick | General Counsel | Jan 05, 2022 | Sale | $61.72 | 32,500 | 2,005,875 | 368,941 | Jan 07, 2022, 08:16 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 05, 2022 | Sale | $61.70 | 40,000 | 2,467,941 | 488,097 | Jan 06, 2022, 08:58 PM |
Hamilton James C | Senior Vice President | Jan 05, 2022 | Sale | $61.72 | 6,250 | 385,773 | 159,585 | Jan 06, 2022, 08:56 PM |
Hamilton James C | Senior Vice President | Jan 04, 2022 | Sale | $65.49 | 19,375 | 1,268,818 | 171,295 | Jan 06, 2022, 08:56 PM |
Waddill William D. | Director | Jan 03, 2022 | Sale | $64.72 | 4,500 | 291,244 | 28,150 | Jan 04, 2022, 09:35 PM |
OLUKOTUN ADEOYE Y | Director | Jan 03, 2022 | Sale | $64.75 | 4,050 | 262,233 | 7,110 | Jan 04, 2022, 09:33 PM |
De Backer Marianne | Director | Jan 03, 2022 | Sale | $64.71 | 4,500 | 291,177 | 19,256 | Jan 04, 2022, 09:31 PM |
PERRY MICHAEL S | Director | Jan 03, 2022 | Sale | $64.71 | 4,500 | 291,192 | 87,372 | Jan 04, 2022, 09:30 PM |
O'Brien Patrick | General Counsel | Dec 31, 2021 | Option Exercise | $6.15 | 28,000 | 172,200 | 321,375 | Jan 04, 2022, 09:26 PM |
GIVEN DOUGLAS B | Director | Dec 28, 2021 | Buy | $66.37 | 655 | 43,472 | 109,868 | Dec 29, 2021, 08:44 PM |
Ferrari Mauro | Director | Dec 28, 2021 | Sale | $66.82 | 3,400 | 227,188 | 36,571 | Dec 29, 2021, 08:41 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 23, 2021 | Option Exercise | $5.19 | 11,806 | 61,273 | 3,245,828 | Dec 23, 2021, 09:52 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 15, 2021 | Sale | $67.56 | 60,000 | 4,053,431 | 3,253,165 | Dec 17, 2021, 08:14 PM |
San Martin Javier | Chief Medical Officer | Nov 19, 2021 | Sale | $69.31 | 19,500 | 1,351,589 | 116,796 | Nov 22, 2021, 04:56 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 20, 2021 | Sale | $66.23 | 15,000 | 993,450 | 3,329,022 | Oct 22, 2021, 05:58 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 22, 2021 | Sale | $65.63 | 50,000 | 3,281,532 | 3,284,852 | Oct 22, 2021, 05:58 PM |
OLUKOTUN ADEOYE Y | Director | Sep 13, 2021 | Sale | $63.76 | 5,000 | 318,800 | 11,750 | Sep 14, 2021, 05:25 PM |
GIVEN DOUGLAS B | Director | Sep 09, 2021 | Sale | $65.24 | 5,000 | 326,200 | 109,868 | Sep 10, 2021, 04:53 PM |
De Backer Marianne | Director | Jun 24, 2021 | Sale | $89.85 | 5,000 | 449,250 | 21,500 | Jun 25, 2021, 06:59 PM |
Hassard James | Chief Commercial Officer | Jun 22, 2021 | Sale | $89.22 | 3,625 | 323,423 | 105,750 | Jun 24, 2021, 06:44 PM |
GIVEN DOUGLAS B | Director | Feb 22, 2021 | Sale | $88.73 | 1,125 | 99,821 | 13,875 | Feb 24, 2021, 06:51 PM |
O'Brien Patrick | General Counsel | Feb 08, 2021 | Option Exercise | $5.22 | 90,000 | 469,800 | 383,375 | Feb 10, 2021, 05:56 PM |
O'Brien Patrick | General Counsel | Feb 08, 2021 | Sale | $88.46 | 90,000 | 7,961,240 | 375,414 | Feb 10, 2021, 05:56 PM |
GIVEN DOUGLAS B | Director | Jan 15, 2021 | Sale | $83.28 | 3,000 | 249,840 | 12,500 | Jan 19, 2021, 05:58 PM |
Hamilton James C | Senior Vice President | Jan 14, 2021 | Sale | $81.29 | 10,000 | 812,942 | 130,064 | Jan 15, 2021, 05:49 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 11, 2021 | Sale | $81.02 | 11,597 | 939,589 | 445,446 | Jan 12, 2021, 06:06 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 12, 2021 | Sale | $81.00 | 1,441 | 116,721 | 444,005 | Jan 12, 2021, 06:06 PM |
Hassard James | Chief Commercial Officer | Jan 07, 2021 | Sale | $75.00 | 15,625 | 1,171,875 | 109,375 | Jan 08, 2021, 06:05 PM |
O'Brien Patrick | General Counsel | Jan 06, 2021 | Sale | $72.41 | 25,000 | 1,810,346 | 317,233 | Jan 07, 2021, 06:11 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 06, 2021 | Sale | $72.44 | 30,625 | 2,218,477 | 486,568 | Jan 07, 2021, 06:08 PM |
Hamilton James C | Senior Vice President | Jan 06, 2021 | Sale | $72.48 | 19,375 | 1,404,276 | 154,925 | Jan 07, 2021, 06:02 PM |
Hamilton James C | Senior Vice President | Jan 05, 2021 | Sale | $72.53 | 19,375 | 1,405,303 | 171,200 | Jan 07, 2021, 06:02 PM |
PERRY MICHAEL S | Director | Jan 04, 2021 | Sale | $76.09 | 4,000 | 304,360 | 90,000 | Jan 05, 2021, 06:14 PM |
GIVEN DOUGLAS B | Director | Jan 04, 2021 | Sale | $76.08 | 4,000 | 304,320 | 119,368 | Jan 05, 2021, 06:11 PM |
Waddill William D. | Director | Jan 04, 2021 | Sale | $76.08 | 3,750 | 285,300 | 30,250 | Jan 05, 2021, 06:01 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 18, 2020 | Option Exercise | $5.73 | 40,510 | 232,006 | 2,545,747 | Dec 22, 2020, 05:55 PM |
GIVEN DOUGLAS B | Director | Dec 17, 2020 | Sale | $79.59 | 500 | 39,795 | 15,000 | Dec 18, 2020, 06:26 PM |
GIVEN DOUGLAS B | Director | Dec 17, 2020 | Sale | $79.30 | 9,075 | 719,648 | 114,738 | Dec 18, 2020, 06:26 PM |
Waddill William D. | Director | Dec 10, 2020 | Sale | $71.26 | 3,000 | 213,780 | 26,800 | Dec 11, 2020, 06:16 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 09, 2020 | Option Exercise | $2.01 | 38,676 | 77,739 | 2,543,913 | Dec 10, 2020, 07:07 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 08, 2020 | Option Exercise | $2.01 | 16,324 | 32,811 | 2,521,561 | Dec 10, 2020, 07:07 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 09, 2020 | Sale | $69.06 | 38,676 | 2,670,805 | 2,527,187 | Dec 10, 2020, 07:07 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 08, 2020 | Sale | $67.97 | 16,324 | 1,109,542 | 2,505,237 | Dec 10, 2020, 07:07 PM |
Bradshaw Curt | Chief Scientific Officer | Nov 20, 2020 | Sale | $68.73 | 15,625 | 1,073,906 | 0 | Nov 23, 2020, 05:58 PM |
Bradshaw Curt | Chief Scientific Officer | Nov 19, 2020 | Sale | $69.39 | 15,625 | 1,084,219 | 15,625 | Nov 23, 2020, 05:58 PM |
San Martin Javier | Chief Medical Officer | Nov 19, 2020 | Sale | $69.39 | 19,500 | 1,353,105 | 130,500 | Nov 20, 2020, 06:03 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Nov 09, 2020 | Option Exercise | $14.54 | 43,505 | 632,563 | 471,173 | Nov 12, 2020, 05:49 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Nov 09, 2020 | Sale | $69.37 | 43,505 | 3,018,071 | 445,333 | Nov 12, 2020, 05:49 PM |
De Backer Marianne | Director | Oct 08, 2020 | Buy | $50.47 | 1,000 | 50,465 | 17,500 | Oct 26, 2020, 06:02 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 23, 2020 | Sale | $58.21 | 100,000 | 5,821,032 | 2,517,509 | Oct 23, 2020, 07:35 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Oct 20, 2020 | Option Exercise | $6.15 | 29,166 | 179,371 | 456,834 | Oct 22, 2020, 06:02 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Oct 20, 2020 | Sale | $54.04 | 29,166 | 1,576,131 | 427,668 | Oct 22, 2020, 06:02 PM |
Ferrari Mauro | Director | Oct 09, 2020 | Sale | $48.00 | 10,000 | 480,000 | 30,971 | Oct 13, 2020, 06:01 PM |
Anzalone Christopher Richard | Chief Executive Officer | Aug 13, 2020 | Option Exercise | $9.90 | 50,000 | 495,000 | 2,655,237 | Aug 14, 2020, 06:08 PM |
Anzalone Christopher Richard | Chief Executive Officer | Aug 13, 2020 | Sale | $41.35 | 50,000 | 2,067,500 | 2,605,237 | Aug 14, 2020, 06:08 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jun 25, 2020 | Sale | $38.81 | 100,000 | 3,881,017 | 2,605,260 | Jun 26, 2020, 06:02 PM |
De Backer Marianne | Director | Mar 16, 2020 | Buy | $23.94 | 500 | 11,970 | 15,500 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Mar 12, 2020 | Buy | $24.80 | 500 | 12,400 | 15,000 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Mar 11, 2020 | Buy | $28.60 | 500 | 14,300 | 14,500 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Feb 28, 2020 | Buy | $34.39 | 500 | 17,195 | 14,000 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Feb 27, 2020 | Buy | $35.07 | 500 | 17,535 | 13,500 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Jun 15, 2020 | Buy | $31.33 | 500 | 15,665 | 16,500 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Jan 13, 2020 | Buy | $54.95 | 500 | 27,475 | 13,000 | Jun 24, 2020, 06:10 PM |
De Backer Marianne | Director | Apr 15, 2020 | Buy | $35.40 | 500 | 17,700 | 16,000 | Jun 24, 2020, 06:10 PM |
PERRY MICHAEL S | Director | May 14, 2020 | Option Exercise | $3.70 | 77,000 | 285,200 | 85,000 | May 18, 2020, 06:27 PM |
PERRY MICHAEL S | Director | May 12, 2020 | Sale | $35.83 | 36,000 | 1,289,891 | 14,100 | May 13, 2020, 06:48 PM |
Waddill William D. | Director | May 11, 2020 | Sale | $36.54 | 26,000 | 950,040 | 28,000 | May 13, 2020, 06:45 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 28, 2020 | Option Exercise | $8.61 | 4,197 | 36,131 | 855,831 | Apr 29, 2020, 07:19 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 27, 2020 | Option Exercise | $5.19 | 200 | 1,038 | 851,934 | Apr 29, 2020, 07:19 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 28, 2020 | Sale | $40.00 | 5,101 | 204,040 | 855,331 | Apr 29, 2020, 07:19 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 27, 2020 | Sale | $40.00 | 300 | 12,000 | 851,734 | Apr 29, 2020, 07:19 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 20, 2020 | Option Exercise | $8.14 | 16,256 | 132,286 | 875,249 | Apr 22, 2020, 07:00 PM |
GIVEN BRUCE D | Chief Operating Officer | Apr 20, 2020 | Sale | $40.00 | 23,515 | 940,600 | 871,449 | Apr 22, 2020, 07:00 PM |
GIVEN DOUGLAS B | Director | Apr 14, 2020 | Sale | $36.89 | 25,000 | 922,250 | 155,925 | Apr 16, 2020, 07:47 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Feb 25, 2020 | Option Exercise | $8.84 | 43,445 | 384,145 | 427,668 | Feb 27, 2020, 05:41 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 21, 2020 | Option Exercise | $5.19 | 33,351 | 173,092 | 424,536 | Jan 23, 2020, 06:15 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 21, 2020 | Sale | $49.44 | 40,313 | 1,992,925 | 418,139 | Jan 23, 2020, 06:15 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 06, 2020 | Sale | $60.13 | 35,613 | 2,141,285 | 882,759 | Jan 08, 2020, 06:35 PM |
O'Brien Patrick | General Counsel | Jan 06, 2020 | Sale | $60.12 | 14,625 | 879,261 | 267,406 | Jan 08, 2020, 06:33 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 06, 2020 | Sale | $60.11 | 20,000 | 1,202,201 | 403,592 | Jan 08, 2020, 06:31 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 24, 2019 | Sale | $63.50 | 83,333 | 5,291,646 | 1,805,237 | Dec 27, 2019, 04:54 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 13, 2019 | Sale | $66.73 | 83,333 | 5,560,489 | 1,962,952 | Dec 13, 2019, 06:35 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 12, 2019 | Sale | $67.50 | 100,000 | 6,749,630 | 2,048,684 | Dec 13, 2019, 06:35 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 02, 2019 | Sale | $69.15 | 37,967 | 2,625,570 | 2,116,160 | Dec 04, 2019, 06:48 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 03, 2019 | Sale | $61.58 | 12,033 | 740,952 | 2,079,925 | Dec 04, 2019, 06:48 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Nov 05, 2019 | Option Exercise | $5.19 | 12,649 | 65,648 | 326,185 | Nov 07, 2019, 06:45 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Nov 01, 2019 | Option Exercise | $7.75 | 37,884 | 293,601 | 351,420 | Nov 01, 2019, 07:32 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Nov 01, 2019 | Sale | $40.85 | 37,884 | 1,547,378 | 330,156 | Nov 01, 2019, 07:32 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 10, 2019 | Option Exercise | $5.20 | 56,325 | 292,890 | 2,178,228 | Oct 11, 2019, 07:31 PM |
Anzalone Christopher Richard | Chief Executive Officer | Oct 10, 2019 | Sale | $31.83 | 56,325 | 1,792,825 | 2,121,903 | Oct 11, 2019, 07:31 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 25, 2019 | Sale | $28.25 | 20,000 | 565,000 | 2,121,903 | Sep 27, 2019, 09:16 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 24, 2019 | Option Exercise | $5.10 | 66,645 | 339,889 | 2,208,548 | Sep 24, 2019, 09:12 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 23, 2019 | Option Exercise | $5.10 | 41,755 | 212,950 | 2,183,658 | Sep 24, 2019, 09:12 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 20, 2019 | Option Exercise | $5.10 | 4,250 | 21,675 | 2,146,153 | Sep 24, 2019, 09:12 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 24, 2019 | Sale | $28.20 | 66,645 | 1,879,240 | 2,154,576 | Sep 24, 2019, 09:12 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 23, 2019 | Sale | $29.04 | 41,755 | 1,212,565 | 2,141,903 | Sep 24, 2019, 09:12 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 20, 2019 | Sale | $29.00 | 4,250 | 123,250 | 2,141,903 | Sep 24, 2019, 09:12 PM |
PERRY MICHAEL S | Director | Sep 11, 2019 | Sale | $30.00 | 85,000 | 2,550,000 | 36,000 | Sep 11, 2019, 08:09 PM |
PERRY MICHAEL S | Director | Sep 09, 2019 | Sale | $28.90 | 100,000 | 2,890,000 | 121,000 | Sep 11, 2019, 08:09 PM |
Ferrari Mauro | Director | Jun 26, 2019 | Sale | $27.61 | 17,756 | 490,243 | 1,900 | Jun 28, 2019, 07:19 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 31, 2019 | Option Exercise | $4.94 | 35,000 | 172,800 | 313,536 | Jun 03, 2019, 06:12 PM |
O'Brien Patrick | General Counsel | May 28, 2019 | Sale | $24.88 | 30,000 | 746,400 | 203,000 | May 29, 2019, 07:01 PM |
Anzalone Christopher Richard | Chief Executive Officer | May 24, 2019 | Option Exercise | $2.13 | 49,448 | 105,110 | 2,141,903 | May 29, 2019, 06:57 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 21, 2019 | Sale | $22.00 | 27,071 | 595,562 | 278,536 | May 22, 2019, 05:44 PM |
Anzalone Christopher Richard | Chief Executive Officer | Apr 03, 2019 | Sale | $19.30 | 50,000 | 965,000 | 2,092,455 | Apr 05, 2019, 06:57 PM |
GIVEN BRUCE D | Chief Operating Officer | Mar 01, 2019 | Option Exercise | $2.01 | 42,500 | 85,425 | 687,106 | Mar 01, 2019, 08:42 PM |
GIVEN BRUCE D | Chief Operating Officer | Mar 01, 2019 | Sale | $19.99 | 42,500 | 849,575 | 644,606 | Mar 01, 2019, 08:42 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 25, 2019 | Option Exercise | $2.01 | 42,500 | 85,425 | 687,106 | Feb 27, 2019, 07:08 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 25, 2019 | Sale | $18.98 | 42,500 | 806,650 | 644,606 | Feb 27, 2019, 07:08 PM |
GIVEN DOUGLAS B | Director | Feb 26, 2019 | Option Exercise | $3.92 | 65,000 | 254,570 | 240,130 | Feb 26, 2019, 07:32 PM |
GIVEN DOUGLAS B | Director | Feb 22, 2019 | Sale | $18.05 | 3,000 | 54,150 | 175,130 | Feb 26, 2019, 07:32 PM |
GIVEN DOUGLAS B | Director | Feb 26, 2019 | Sale | $19.25 | 65,000 | 1,251,250 | 175,130 | Feb 26, 2019, 07:32 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Feb 19, 2019 | Option Exercise | $5.20 | 8,000 | 41,600 | 313,607 | Feb 20, 2019, 08:12 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Feb 19, 2019 | Sale | $18.00 | 8,000 | 144,000 | 305,607 | Feb 20, 2019, 08:12 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 19, 2019 | Option Exercise | $2.01 | 42,500 | 85,425 | 687,106 | Feb 20, 2019, 08:09 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 15, 2019 | Sale | $17.67 | 26,250 | 463,838 | 644,606 | Feb 20, 2019, 08:09 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 19, 2019 | Sale | $17.98 | 42,500 | 764,150 | 644,606 | Feb 20, 2019, 08:09 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 12, 2019 | Option Exercise | $2.01 | 42,500 | 85,425 | 713,356 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 11, 2019 | Option Exercise | $2.62 | 11,667 | 30,568 | 825,023 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 08, 2019 | Option Exercise | $2.62 | 11,667 | 30,568 | 859,523 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 12, 2019 | Sale | $17.06 | 42,500 | 725,050 | 670,856 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 11, 2019 | Sale | $15.96 | 154,167 | 2,460,995 | 727,856 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 08, 2019 | Sale | $15.34 | 46,167 | 708,202 | 813,356 | Feb 12, 2019, 08:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 05, 2019 | Sale | $14.48 | 22,500 | 325,800 | 847,856 | Feb 07, 2019, 08:35 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 01, 2019 | Sale | $13.85 | 28,500 | 394,725 | 870,356 | Feb 01, 2019, 07:51 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 23, 2019 | Sale | $13.15 | 17,500 | 230,125 | 898,856 | Jan 24, 2019, 08:53 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 22, 2019 | Sale | $13.59 | 152,000 | 2,065,680 | 916,356 | Jan 24, 2019, 08:53 PM |
GIVEN DOUGLAS B | Director | Jan 22, 2019 | Sale | $13.58 | 3,000 | 40,740 | 178,130 | Jan 24, 2019, 08:46 PM |
O'Brien Patrick | General Counsel | Jan 18, 2019 | Sale | $14.43 | 72,000 | 1,038,960 | 233,000 | Jan 18, 2019, 07:02 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 17, 2019 | Sale | $14.55 | 81,875 | 1,191,281 | 305,607 | Jan 18, 2019, 07:00 PM |
Li Zhen | Snr. VP, Chem and Non-Clin Dev | Jan 14, 2019 | Sale | $14.34 | 40,500 | 580,770 | 201,700 | Jan 16, 2019, 08:24 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 14, 2019 | Option Exercise | $2.90 | 12,666 | 36,765 | 1,111,022 | Jan 16, 2019, 08:18 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 14, 2019 | Sale | $14.40 | 42,666 | 614,390 | 1,068,356 | Jan 16, 2019, 08:18 PM |
Waddill William D. | Director | Jan 11, 2019 | Sale | $14.77 | 8,500 | 125,545 | 46,500 | Jan 11, 2019, 06:15 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jan 02, 2019 | Sale | $11.98 | 8,333 | 99,829 | 387,482 | Jan 03, 2019, 07:55 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 02, 2019 | Sale | $11.98 | 20,000 | 239,600 | 1,098,356 | Jan 03, 2019, 07:53 PM |
GIVEN DOUGLAS B | Director | Dec 27, 2018 | Sale | $12.00 | 3,000 | 36,000 | 145,130 | Dec 28, 2018, 05:20 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 19, 2018 | Sale | $13.92 | 90,000 | 1,252,800 | 1,542,455 | Dec 21, 2018, 05:15 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 12, 2018 | Sale | $14.07 | 90,000 | 1,266,300 | 1,632,455 | Dec 14, 2018, 05:18 PM |
GIVEN DOUGLAS B | Director | Nov 23, 2018 | Sale | $12.74 | 3,000 | 38,220 | 148,130 | Nov 26, 2018, 09:09 PM |
Anzalone Christopher Richard | Chief Executive Officer | Nov 09, 2018 | Sale | $14.39 | 81,500 | 1,172,705 | 1,727,755 | Nov 09, 2018, 07:01 PM |
Leone Peter Brian | VP, Strategic Bus. Initiatives | Oct 19, 2018 | Option Exercise | $6.20 | 131,137 | 812,512 | 261,137 | Oct 23, 2018, 07:59 PM |
Leone Peter Brian | VP, Strategic Bus. Initiatives | Oct 19, 2018 | Sale | $13.49 | 131,137 | 1,769,038 | 130,000 | Oct 23, 2018, 07:59 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Sep 06, 2018 | Option Exercise | $3.57 | 45,000 | 160,500 | 355,815 | Sep 10, 2018, 06:32 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Sep 06, 2018 | Sale | $19.34 | 45,000 | 870,200 | 330,815 | Sep 10, 2018, 06:32 PM |
Anzalone Christopher Richard | Chief Executive Officer | Sep 04, 2018 | Sale | $14.45 | 64,834 | 936,851 | 1,803,955 | Sep 05, 2018, 04:23 PM |
Anzalone Christopher Richard | Chief Executive Officer | Aug 31, 2018 | Sale | $14.45 | 100,000 | 1,445,000 | 1,868,789 | Sep 05, 2018, 04:23 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jun 19, 2018 | Option Exercise | $2.01 | 20,000 | 40,200 | 330,815 | Jun 20, 2018, 09:18 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Jun 19, 2018 | Sale | $14.01 | 20,000 | 280,200 | 310,815 | Jun 20, 2018, 09:18 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 31, 2018 | Option Exercise | $2.01 | 12,600 | 25,326 | 323,415 | Jun 01, 2018, 05:34 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 30, 2018 | Option Exercise | $2.01 | 1,400 | 2,814 | 312,215 | Jun 01, 2018, 05:34 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 31, 2018 | Sale | $11.00 | 12,600 | 138,600 | 310,815 | Jun 01, 2018, 05:34 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | May 30, 2018 | Sale | $11.00 | 1,400 | 15,400 | 310,815 | Jun 01, 2018, 05:34 PM |
GIVEN DOUGLAS B | Director | Apr 24, 2018 | Sale | $6.63 | 25,000 | 165,750 | 155,000 | Apr 25, 2018, 07:40 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Mar 27, 2018 | Option Exercise | $2.01 | 20,000 | 40,200 | 330,815 | Mar 27, 2018, 07:46 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Mar 27, 2018 | Sale | $8.00 | 20,000 | 160,000 | 310,815 | Mar 27, 2018, 07:46 PM |
Anzalone Christopher Richard | Chief Executive Officer | Mar 16, 2018 | Sale | $7.40 | 26,000 | 192,400 | 1,968,789 | Mar 16, 2018, 06:09 PM |
Anzalone Christopher Richard | Chief Executive Officer | Mar 15, 2018 | Sale | $7.41 | 100,000 | 741,000 | 1,994,789 | Mar 15, 2018, 06:58 PM |
Anzalone Christopher Richard | Chief Executive Officer | Mar 14, 2018 | Sale | $7.44 | 100,000 | 744,000 | 2,094,789 | Mar 15, 2018, 06:58 PM |
Anzalone Christopher Richard | Chief Executive Officer | Mar 13, 2018 | Sale | $7.43 | 100,000 | 743,000 | 2,194,789 | Mar 15, 2018, 06:58 PM |
GIVEN BRUCE D | Chief Operating Officer | Mar 05, 2018 | Sale | $6.73 | 20,000 | 134,600 | 908,356 | Mar 05, 2018, 08:48 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Mar 05, 2018 | Option Exercise | $6.66 | 8,208 | 54,665 | 310,815 | Mar 05, 2018, 08:46 PM |
GIVEN BRUCE D | Chief Operating Officer | Jan 01, 2018 | Sale | $3.69 | 20,000 | 73,800 | 928,356 | Jan 03, 2018, 07:25 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 13, 2016 | Option Exercise | $1.27 | 300,444 | 381,564 | 816,789 | Dec 15, 2016, 09:46 PM |
GIVEN DOUGLAS B | Director | Oct 14, 2016 | Sale | $6.72 | 12,000 | 80,640 | 70,000 | Oct 18, 2016, 07:53 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 22, 2016 | Option Exercise | $2.01 | 13,100 | 26,331 | 128,789 | Aug 26, 2016, 05:52 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 23, 2016 | Option Exercise | $2.01 | 6,900 | 13,869 | 122,589 | Aug 26, 2016, 05:52 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 23, 2016 | Sale | $8.00 | 6,900 | 55,200 | 115,689 | Aug 26, 2016, 05:52 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 22, 2016 | Sale | $8.00 | 13,100 | 104,800 | 115,689 | Aug 26, 2016, 05:52 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 23, 2016 | Option Exercise | $2.01 | 6,900 | 13,869 | 122,589 | Aug 24, 2016, 06:39 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 22, 2016 | Option Exercise | $2.01 | 13,100 | 26,331 | 128,789 | Aug 24, 2016, 06:39 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 23, 2016 | Sale | $8.00 | 6,900 | 55,200 | 115,689 | Aug 24, 2016, 06:39 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Aug 22, 2016 | Sale | $8.00 | 13,100 | 104,800 | 115,689 | Aug 24, 2016, 06:39 PM |
Anzalone Christopher Richard | Chief Executive Officer | Jun 30, 2016 | Option Exercise | $5.09 | 15,772 | 80,279 | 1,117,233 | Jul 05, 2016, 06:11 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Mar 04, 2016 | Option Exercise | $4.33 | 6,263 | 27,119 | 115,689 | Mar 08, 2016, 06:39 PM |
GIVEN BRUCE D | Chief Operating Officer | Mar 04, 2016 | Option Exercise | $4.33 | 13,675 | 59,213 | 393,356 | Mar 08, 2016, 06:36 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Feb 06, 2016 | Option Exercise | $3.46 | 13,048 | 45,146 | 121,952 | Feb 09, 2016, 06:45 PM |
GIVEN BRUCE D | Chief Operating Officer | Feb 06, 2016 | Option Exercise | $3.46 | 17,969 | 62,173 | 407,031 | Feb 09, 2016, 06:41 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Dec 30, 2015 | Option Exercise | $6.13 | 13,153 | 80,628 | 108,347 | Jan 04, 2016, 07:19 PM |
Myszkowski Kenneth Allen | Chief Financial Officer | Dec 30, 2015 | Sale | $6.13 | 23,347 | 143,117 | 85,000 | Jan 04, 2016, 07:19 PM |
Anzalone Christopher Richard | Chief Executive Officer | Dec 30, 2015 | Option Exercise | $6.13 | 58,712 | 359,905 | 561,461 | Jan 04, 2016, 07:15 PM |
Ferrari Mauro | Director | Oct 28, 2013 | Buy | $7.62 | 400 | 3,047 | 4,251 | Jan 14, 2015, 06:10 PM |
Ferrari Mauro | Director | Oct 09, 2013 | Buy | $6.19 | 1,900 | 11,761 | 3,851 | Jan 14, 2015, 06:10 PM |
Lewis David L. | Chief Scientific Officer | Jan 05, 2015 | Option Exercise | $2.01 | 15,000 | 30,150 | 15,000 | Jan 07, 2015, 05:50 PM |
Lewis David L. | Chief Scientific Officer | Jan 05, 2015 | Sale | $8.01 | 15,000 | 120,103 | 0 | Jan 07, 2015, 05:50 PM |
Anzalone Christopher Richard | President and CEO | Oct 15, 2014 | Buy | $6.32 | 16,000 | 101,120 | 260,173 | Oct 15, 2014, 06:33 PM |
Anzalone Christopher Richard | President and CEO | Oct 15, 2014 | Buy | $6.32 | 16,000 | 101,120 | 260,173 | Oct 15, 2014, 05:31 PM |
McKenney Charles | Director | Oct 01, 2014 | Option Exercise | $5.19 | 2,500 | 12,975 | 19,720 | Oct 01, 2014, 07:38 PM |
McKenney Charles | Director | Oct 01, 2014 | Sale | $14.70 | 2,500 | 36,748 | 17,220 | Oct 01, 2014, 07:38 PM |
Lewis David L. | Chief Scientific Officer | Sep 30, 2014 | Option Exercise | $2.01 | 15,000 | 30,150 | 15,000 | Sep 30, 2014, 05:59 PM |
Lewis David L. | Chief Scientific Officer | Sep 30, 2014 | Sale | $15.02 | 15,000 | 225,350 | 0 | Sep 30, 2014, 05:59 PM |
GIVEN DOUGLAS B | Director | Sep 26, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 22,000 | Sep 30, 2014, 05:58 PM |
GIVEN DOUGLAS B | Director | Sep 26, 2014 | Sale | $15.24 | 2,000 | 30,480 | 20,000 | Sep 30, 2014, 05:58 PM |
GIVEN DOUGLAS B | Director | Aug 15, 2014 | Option Exercise | $2.01 | 5,000 | 10,050 | 25,000 | Aug 19, 2014, 05:15 PM |
GIVEN DOUGLAS B | Director | Aug 15, 2014 | Sale | $13.90 | 5,000 | 69,500 | 20,000 | Aug 19, 2014, 05:15 PM |
Myszkowski Kenneth Allen | CFO | Aug 15, 2014 | Option Exercise | $6.32 | 40,000 | 252,850 | 111,500 | Aug 19, 2014, 05:15 PM |
Myszkowski Kenneth Allen | CFO | Aug 15, 2014 | Sale | $14.02 | 40,000 | 560,860 | 71,500 | Aug 19, 2014, 05:15 PM |
McKenney Charles | Director | Jun 09, 2014 | Option Exercise | $2.39 | 22,000 | 52,480 | 39,220 | Jun 10, 2014, 09:28 PM |
McKenney Charles | Director | Jun 09, 2014 | Sale | $14.32 | 22,000 | 315,005 | 17,220 | Jun 10, 2014, 09:28 PM |
Myszkowski Kenneth Allen | CFO | Feb 12, 2014 | Option Exercise | $2.01 | 16,000 | 32,160 | 87,500 | Feb 12, 2014, 07:15 PM |
Myszkowski Kenneth Allen | CFO | Feb 12, 2014 | Sale | $18.77 | 16,000 | 300,290 | 71,500 | Feb 12, 2014, 07:15 PM |
FRYKMAN EDWARD W | Director | Feb 07, 2014 | Option Exercise | $10.00 | 5,000 | 50,000 | 27,000 | Feb 10, 2014, 07:45 PM |
FRYKMAN EDWARD W | Director | Feb 07, 2014 | Sale | $15.98 | 3,148 | 50,296 | 23,852 | Feb 10, 2014, 07:45 PM |
Lewis David L. | Chief Scientific Officer | Jan 02, 2014 | Option Exercise | $4.37 | 15,000 | 65,525 | 15,000 | Jan 06, 2014, 05:37 PM |
Lewis David L. | Chief Scientific Officer | Jan 02, 2014 | Sale | $10.29 | 15,000 | 154,292 | 0 | Jan 06, 2014, 05:37 PM |
McKenney Charles | Director | Oct 11, 2013 | Option Exercise | $7.58 | 1,200 | 9,096 | 2,220 | Oct 15, 2013, 04:05 PM |
Anzalone Christopher Richard | President and CEO | Aug 31, 2010 | Buy | $0.89 | 10,000 | 8,900 | 341,729 | Aug 31, 2010, 05:58 PM |
Anzalone Christopher Richard | President and CEO | Aug 27, 2010 | Buy | $0.89 | 10,000 | 8,900 | 331,729 | Aug 30, 2010, 04:19 PM |
Myszkowski Kenneth Allen | CFO | Aug 27, 2010 | Buy | $0.89 | 15,000 | 13,350 | 15,000 | Aug 30, 2010, 04:16 PM |
Owner | Relationship | Date | Value($) |
Hamilton James C | Chief Discovery/Trans Medicine | 04/01/2024 | 168,180 |
Lu Hongbo | Director | 03/20/2024 | 27,500 |
Lu Hongbo | Director | 03/19/2024 | 28,000 |
Lu Hongbo | Director | 03/18/2024 | 27,490 |
Myszkowski Kenneth Allen | Chief Financial Officer | 03/06/2024 | 1,407,600 |
Anzalone Christopher Richard | Chief Executive Officer | 01/31/2024 | 836,035 |
Anzalone Christopher Richard | Chief Executive Officer | 01/31/2024 | 1,860,019 |
Hamilton James C | Chief Discovery/Trans Medicine | 01/12/2024 | 292,904 |
GIVEN DOUGLAS B | Director | 01/11/2024 | 110,788 |
Waddill William D. | Director | 01/11/2024 | 149,759 |
Ferrari Mauro | Director | 01/11/2024 | 119,787 |
Vakiener Victoria | Director | 01/11/2024 | 179,813 |
Oliver Tracie | Chief Commercial Officer | 01/05/2024 | 2,508 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/05/2024 | 567,910 |
San Martin Javier | Chief Medical Officer | 01/05/2024 | 292,804 |
Hamilton James C | Chief Discovery/Trans Medicine | 01/05/2024 | 1,130,748 |
Hamilton James C | Chief Discovery/Trans Medicine | 01/03/2024 | 202,781 |
O'Brien Patrick | COO and General Counsel | 01/03/2024 | 282,439 |
O'Brien Patrick | COO and General Counsel | 01/05/2024 | 805,716 |
O'Brien Patrick | COO and General Counsel | 01/04/2024 | 52,208 |
Anzalone Christopher Richard | Chief Executive Officer | 01/02/2024 | 308,637 |
Anzalone Christopher Richard | Chief Executive Officer | 12/20/2023 | 342,480 |
Ferrari Mauro | Director | 12/15/2023 | 380,820 |
PERRY MICHAEL S | Director | 12/15/2023 | 380,820 |
OLUKOTUN ADEOYE Y | Director | 12/15/2023 | 380,820 |
Vakiener Victoria | Director | 12/15/2023 | 380,820 |
GIVEN DOUGLAS B | Director | 12/15/2023 | 380,820 |
Waddill William D. | Director | 12/15/2023 | 380,820 |
San Martin Javier | Chief Medical Officer | 11/20/2023 | 567,315 |
Anzalone Christopher Richard | Chief Executive Officer | 10/25/2023 | 589,223 |
Vakiener Victoria | Director | 09/28/2023 | 40,811 |
Anzalone Christopher Richard | Chief Executive Officer | 09/18/2023 | 274,336 |
Anzalone Christopher Richard | Chief Executive Officer | 09/18/2023 | 1,624,223 |
Oliver Tracie | Chief Commercial Officer | 07/03/2023 | 315,142 |
Hamilton James C | Chief Discovery/Trans Medicine | 06/30/2023 | 106,590 |
Myszkowski Kenneth Allen | Chief Financial Officer | 06/27/2023 | 543,000 |
GIVEN DOUGLAS B | Director | 05/05/2023 | 265,850 |
Anzalone Christopher Richard | Chief Executive Officer | 05/03/2023 | 110,405 |
Anzalone Christopher Richard | Chief Executive Officer | 05/04/2023 | 100,500 |
Anzalone Christopher Richard | Chief Executive Officer | 05/03/2023 | 2,149,882 |
Anzalone Christopher Richard | Chief Executive Officer | 05/04/2023 | 1,975,792 |
OLUKOTUN ADEOYE Y | Director | 03/03/2023 | 370,578 |
GIVEN DOUGLAS B | Director | 02/27/2023 | 28,542 |
Waddill William D. | Director | 01/09/2023 | 96,000 |
O'Brien Patrick | COO and General Counsel | 01/05/2023 | 560,850 |
Hamilton James C | Chief Discovery/Trans Medicine | 01/05/2023 | 516,232 |
O'Brien Patrick | COO and General Counsel | 01/03/2023 | 670,802 |
Hamilton James C | Chief Discovery/Trans Medicine | 01/03/2023 | 396,738 |
Myszkowski Kenneth Allen | Chief Financial Officer | 12/29/2022 | 1,225,000 |
O'Brien Patrick | General Counsel | 12/21/2022 | 196,800 |
San Martin Javier | Chief Medical Officer | 11/21/2022 | 584,738 |
Anzalone Christopher Richard | Chief Executive Officer | 09/27/2022 | 1,250,679 |
Anzalone Christopher Richard | Chief Executive Officer | 07/07/2022 | 36,365 |
Anzalone Christopher Richard | Chief Executive Officer | 02/11/2022 | 759,754 |
Anzalone Christopher Richard | Chief Executive Officer | 02/11/2022 | 7,598,865 |
Anzalone Christopher Richard | Chief Executive Officer | 01/07/2022 | 61,273 |
O'Brien Patrick | General Counsel | 01/05/2022 | 2,005,875 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/05/2022 | 2,467,941 |
Hamilton James C | Senior Vice President | 01/05/2022 | 385,773 |
Hamilton James C | Senior Vice President | 01/04/2022 | 1,268,818 |
Waddill William D. | Director | 01/03/2022 | 291,244 |
OLUKOTUN ADEOYE Y | Director | 01/03/2022 | 262,233 |
De Backer Marianne | Director | 01/03/2022 | 291,177 |
PERRY MICHAEL S | Director | 01/03/2022 | 291,192 |
O'Brien Patrick | General Counsel | 12/31/2021 | 172,200 |
GIVEN DOUGLAS B | Director | 12/28/2021 | 43,472 |
Ferrari Mauro | Director | 12/28/2021 | 227,188 |
Anzalone Christopher Richard | Chief Executive Officer | 12/23/2021 | 61,273 |
Anzalone Christopher Richard | Chief Executive Officer | 12/15/2021 | 4,053,431 |
San Martin Javier | Chief Medical Officer | 11/19/2021 | 1,351,589 |
Anzalone Christopher Richard | Chief Executive Officer | 10/20/2021 | 993,450 |
Anzalone Christopher Richard | Chief Executive Officer | 10/22/2021 | 3,281,532 |
OLUKOTUN ADEOYE Y | Director | 09/13/2021 | 318,800 |
GIVEN DOUGLAS B | Director | 09/09/2021 | 326,200 |
De Backer Marianne | Director | 06/24/2021 | 449,250 |
Hassard James | Chief Commercial Officer | 06/22/2021 | 323,423 |
GIVEN DOUGLAS B | Director | 02/22/2021 | 99,821 |
O'Brien Patrick | General Counsel | 02/08/2021 | 469,800 |
O'Brien Patrick | General Counsel | 02/08/2021 | 7,961,240 |
GIVEN DOUGLAS B | Director | 01/15/2021 | 249,840 |
Hamilton James C | Senior Vice President | 01/14/2021 | 812,942 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/11/2021 | 939,589 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/12/2021 | 116,721 |
Hassard James | Chief Commercial Officer | 01/07/2021 | 1,171,875 |
O'Brien Patrick | General Counsel | 01/06/2021 | 1,810,346 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/06/2021 | 2,218,477 |
Hamilton James C | Senior Vice President | 01/06/2021 | 1,404,276 |
Hamilton James C | Senior Vice President | 01/05/2021 | 1,405,303 |
PERRY MICHAEL S | Director | 01/04/2021 | 304,360 |
GIVEN DOUGLAS B | Director | 01/04/2021 | 304,320 |
Waddill William D. | Director | 01/04/2021 | 285,300 |
Anzalone Christopher Richard | Chief Executive Officer | 12/18/2020 | 232,006 |
GIVEN DOUGLAS B | Director | 12/17/2020 | 39,795 |
GIVEN DOUGLAS B | Director | 12/17/2020 | 719,648 |
Waddill William D. | Director | 12/10/2020 | 213,780 |
Anzalone Christopher Richard | Chief Executive Officer | 12/09/2020 | 77,739 |
Anzalone Christopher Richard | Chief Executive Officer | 12/08/2020 | 32,811 |
Anzalone Christopher Richard | Chief Executive Officer | 12/09/2020 | 2,670,805 |
Anzalone Christopher Richard | Chief Executive Officer | 12/08/2020 | 1,109,542 |
Bradshaw Curt | Chief Scientific Officer | 11/20/2020 | 1,073,906 |
Bradshaw Curt | Chief Scientific Officer | 11/19/2020 | 1,084,219 |
San Martin Javier | Chief Medical Officer | 11/19/2020 | 1,353,105 |
Myszkowski Kenneth Allen | Chief Financial Officer | 11/09/2020 | 632,563 |
Myszkowski Kenneth Allen | Chief Financial Officer | 11/09/2020 | 3,018,071 |
De Backer Marianne | Director | 10/08/2020 | 50,465 |
Anzalone Christopher Richard | Chief Executive Officer | 10/23/2020 | 5,821,032 |
Myszkowski Kenneth Allen | Chief Financial Officer | 10/20/2020 | 179,371 |
Myszkowski Kenneth Allen | Chief Financial Officer | 10/20/2020 | 1,576,131 |
Ferrari Mauro | Director | 10/09/2020 | 480,000 |
Anzalone Christopher Richard | Chief Executive Officer | 08/13/2020 | 495,000 |
Anzalone Christopher Richard | Chief Executive Officer | 08/13/2020 | 2,067,500 |
Anzalone Christopher Richard | Chief Executive Officer | 06/25/2020 | 3,881,017 |
De Backer Marianne | Director | 03/16/2020 | 11,970 |
De Backer Marianne | Director | 03/12/2020 | 12,400 |
De Backer Marianne | Director | 03/11/2020 | 14,300 |
De Backer Marianne | Director | 02/28/2020 | 17,195 |
De Backer Marianne | Director | 02/27/2020 | 17,535 |
De Backer Marianne | Director | 06/15/2020 | 15,665 |
De Backer Marianne | Director | 01/13/2020 | 27,475 |
De Backer Marianne | Director | 04/15/2020 | 17,700 |
PERRY MICHAEL S | Director | 05/14/2020 | 285,200 |
PERRY MICHAEL S | Director | 05/12/2020 | 1,289,891 |
Waddill William D. | Director | 05/11/2020 | 950,040 |
GIVEN BRUCE D | Chief Operating Officer | 04/28/2020 | 36,131 |
GIVEN BRUCE D | Chief Operating Officer | 04/27/2020 | 1,038 |
GIVEN BRUCE D | Chief Operating Officer | 04/28/2020 | 204,040 |
GIVEN BRUCE D | Chief Operating Officer | 04/27/2020 | 12,000 |
GIVEN BRUCE D | Chief Operating Officer | 04/20/2020 | 132,286 |
GIVEN BRUCE D | Chief Operating Officer | 04/20/2020 | 940,600 |
GIVEN DOUGLAS B | Director | 04/14/2020 | 922,250 |
Myszkowski Kenneth Allen | Chief Financial Officer | 02/25/2020 | 384,145 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/21/2020 | 173,092 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/21/2020 | 1,992,925 |
GIVEN BRUCE D | Chief Operating Officer | 01/06/2020 | 2,141,285 |
O'Brien Patrick | General Counsel | 01/06/2020 | 879,261 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/06/2020 | 1,202,201 |
Anzalone Christopher Richard | Chief Executive Officer | 12/24/2019 | 5,291,646 |
Anzalone Christopher Richard | Chief Executive Officer | 12/13/2019 | 5,560,489 |
Anzalone Christopher Richard | Chief Executive Officer | 12/12/2019 | 6,749,630 |
Anzalone Christopher Richard | Chief Executive Officer | 12/02/2019 | 2,625,570 |
Anzalone Christopher Richard | Chief Executive Officer | 12/03/2019 | 740,952 |
Myszkowski Kenneth Allen | Chief Financial Officer | 11/05/2019 | 65,648 |
Myszkowski Kenneth Allen | Chief Financial Officer | 11/01/2019 | 293,601 |
Myszkowski Kenneth Allen | Chief Financial Officer | 11/01/2019 | 1,547,378 |
Anzalone Christopher Richard | Chief Executive Officer | 10/10/2019 | 292,890 |
Anzalone Christopher Richard | Chief Executive Officer | 10/10/2019 | 1,792,825 |
Anzalone Christopher Richard | Chief Executive Officer | 09/25/2019 | 565,000 |
Anzalone Christopher Richard | Chief Executive Officer | 09/24/2019 | 339,889 |
Anzalone Christopher Richard | Chief Executive Officer | 09/23/2019 | 212,950 |
Anzalone Christopher Richard | Chief Executive Officer | 09/20/2019 | 21,675 |
Anzalone Christopher Richard | Chief Executive Officer | 09/24/2019 | 1,879,240 |
Anzalone Christopher Richard | Chief Executive Officer | 09/23/2019 | 1,212,565 |
Anzalone Christopher Richard | Chief Executive Officer | 09/20/2019 | 123,250 |
PERRY MICHAEL S | Director | 09/11/2019 | 2,550,000 |
PERRY MICHAEL S | Director | 09/09/2019 | 2,890,000 |
Ferrari Mauro | Director | 06/26/2019 | 490,243 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/31/2019 | 172,800 |
O'Brien Patrick | General Counsel | 05/28/2019 | 746,400 |
Anzalone Christopher Richard | Chief Executive Officer | 05/24/2019 | 105,110 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/21/2019 | 595,562 |
Anzalone Christopher Richard | Chief Executive Officer | 04/03/2019 | 965,000 |
GIVEN BRUCE D | Chief Operating Officer | 03/01/2019 | 85,425 |
GIVEN BRUCE D | Chief Operating Officer | 03/01/2019 | 849,575 |
GIVEN BRUCE D | Chief Operating Officer | 02/25/2019 | 85,425 |
GIVEN BRUCE D | Chief Operating Officer | 02/25/2019 | 806,650 |
GIVEN DOUGLAS B | Director | 02/26/2019 | 254,570 |
GIVEN DOUGLAS B | Director | 02/22/2019 | 54,150 |
GIVEN DOUGLAS B | Director | 02/26/2019 | 1,251,250 |
Myszkowski Kenneth Allen | Chief Financial Officer | 02/19/2019 | 41,600 |
Myszkowski Kenneth Allen | Chief Financial Officer | 02/19/2019 | 144,000 |
GIVEN BRUCE D | Chief Operating Officer | 02/19/2019 | 85,425 |
GIVEN BRUCE D | Chief Operating Officer | 02/15/2019 | 463,838 |
GIVEN BRUCE D | Chief Operating Officer | 02/19/2019 | 764,150 |
GIVEN BRUCE D | Chief Operating Officer | 02/12/2019 | 85,425 |
GIVEN BRUCE D | Chief Operating Officer | 02/11/2019 | 30,568 |
GIVEN BRUCE D | Chief Operating Officer | 02/08/2019 | 30,568 |
GIVEN BRUCE D | Chief Operating Officer | 02/12/2019 | 725,050 |
GIVEN BRUCE D | Chief Operating Officer | 02/11/2019 | 2,460,995 |
GIVEN BRUCE D | Chief Operating Officer | 02/08/2019 | 708,202 |
GIVEN BRUCE D | Chief Operating Officer | 02/05/2019 | 325,800 |
GIVEN BRUCE D | Chief Operating Officer | 02/01/2019 | 394,725 |
GIVEN BRUCE D | Chief Operating Officer | 01/23/2019 | 230,125 |
GIVEN BRUCE D | Chief Operating Officer | 01/22/2019 | 2,065,680 |
GIVEN DOUGLAS B | Director | 01/22/2019 | 40,740 |
O'Brien Patrick | General Counsel | 01/18/2019 | 1,038,960 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/17/2019 | 1,191,281 |
Li Zhen | Snr. VP, Chem and Non-Clin Dev | 01/14/2019 | 580,770 |
GIVEN BRUCE D | Chief Operating Officer | 01/14/2019 | 36,765 |
GIVEN BRUCE D | Chief Operating Officer | 01/14/2019 | 614,390 |
Waddill William D. | Director | 01/11/2019 | 125,545 |
Myszkowski Kenneth Allen | Chief Financial Officer | 01/02/2019 | 99,829 |
GIVEN BRUCE D | Chief Operating Officer | 01/02/2019 | 239,600 |
GIVEN DOUGLAS B | Director | 12/27/2018 | 36,000 |
Anzalone Christopher Richard | Chief Executive Officer | 12/19/2018 | 1,252,800 |
Anzalone Christopher Richard | Chief Executive Officer | 12/12/2018 | 1,266,300 |
GIVEN DOUGLAS B | Director | 11/23/2018 | 38,220 |
Anzalone Christopher Richard | Chief Executive Officer | 11/09/2018 | 1,172,705 |
Leone Peter Brian | VP, Strategic Bus. Initiatives | 10/19/2018 | 812,512 |
Leone Peter Brian | VP, Strategic Bus. Initiatives | 10/19/2018 | 1,769,038 |
Myszkowski Kenneth Allen | Chief Financial Officer | 09/06/2018 | 160,500 |
Myszkowski Kenneth Allen | Chief Financial Officer | 09/06/2018 | 870,200 |
Anzalone Christopher Richard | Chief Executive Officer | 09/04/2018 | 936,851 |
Anzalone Christopher Richard | Chief Executive Officer | 08/31/2018 | 1,445,000 |
Myszkowski Kenneth Allen | Chief Financial Officer | 06/19/2018 | 40,200 |
Myszkowski Kenneth Allen | Chief Financial Officer | 06/19/2018 | 280,200 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/31/2018 | 25,326 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/30/2018 | 2,814 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/31/2018 | 138,600 |
Myszkowski Kenneth Allen | Chief Financial Officer | 05/30/2018 | 15,400 |
GIVEN DOUGLAS B | Director | 04/24/2018 | 165,750 |
Myszkowski Kenneth Allen | Chief Financial Officer | 03/27/2018 | 40,200 |
Myszkowski Kenneth Allen | Chief Financial Officer | 03/27/2018 | 160,000 |
Anzalone Christopher Richard | Chief Executive Officer | 03/16/2018 | 192,400 |
Anzalone Christopher Richard | Chief Executive Officer | 03/15/2018 | 741,000 |
Anzalone Christopher Richard | Chief Executive Officer | 03/14/2018 | 744,000 |
Anzalone Christopher Richard | Chief Executive Officer | 03/13/2018 | 743,000 |
GIVEN BRUCE D | Chief Operating Officer | 03/05/2018 | 134,600 |
Myszkowski Kenneth Allen | Chief Financial Officer | 03/05/2018 | 54,665 |
GIVEN BRUCE D | Chief Operating Officer | 01/01/2018 | 73,800 |
Anzalone Christopher Richard | Chief Executive Officer | 12/13/2016 | 381,564 |
GIVEN DOUGLAS B | Director | 10/14/2016 | 80,640 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/22/2016 | 26,331 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/23/2016 | 13,869 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/23/2016 | 55,200 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/22/2016 | 104,800 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/23/2016 | 13,869 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/22/2016 | 26,331 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/23/2016 | 55,200 |
Myszkowski Kenneth Allen | Chief Financial Officer | 08/22/2016 | 104,800 |
Anzalone Christopher Richard | Chief Executive Officer | 06/30/2016 | 80,279 |
Myszkowski Kenneth Allen | Chief Financial Officer | 03/04/2016 | 27,119 |
GIVEN BRUCE D | Chief Operating Officer | 03/04/2016 | 59,213 |
Myszkowski Kenneth Allen | Chief Financial Officer | 02/06/2016 | 45,146 |
GIVEN BRUCE D | Chief Operating Officer | 02/06/2016 | 62,173 |
Myszkowski Kenneth Allen | Chief Financial Officer | 12/30/2015 | 80,628 |
Myszkowski Kenneth Allen | Chief Financial Officer | 12/30/2015 | 143,117 |
Anzalone Christopher Richard | Chief Executive Officer | 12/30/2015 | 359,905 |
Ferrari Mauro | Director | 10/28/2013 | 3,047 |
Ferrari Mauro | Director | 10/09/2013 | 11,761 |
Lewis David L. | Chief Scientific Officer | 01/05/2015 | 30,150 |
Lewis David L. | Chief Scientific Officer | 01/05/2015 | 120,103 |
Anzalone Christopher Richard | President and CEO | 10/15/2014 | 101,120 |
Anzalone Christopher Richard | President and CEO | 10/15/2014 | 101,120 |
McKenney Charles | Director | 10/01/2014 | 12,975 |
McKenney Charles | Director | 10/01/2014 | 36,748 |
Lewis David L. | Chief Scientific Officer | 09/30/2014 | 30,150 |
Lewis David L. | Chief Scientific Officer | 09/30/2014 | 225,350 |
GIVEN DOUGLAS B | Director | 09/26/2014 | 4,380 |
GIVEN DOUGLAS B | Director | 09/26/2014 | 30,480 |
GIVEN DOUGLAS B | Director | 08/15/2014 | 10,050 |
GIVEN DOUGLAS B | Director | 08/15/2014 | 69,500 |
Myszkowski Kenneth Allen | CFO | 08/15/2014 | 252,850 |
Myszkowski Kenneth Allen | CFO | 08/15/2014 | 560,860 |
McKenney Charles | Director | 06/09/2014 | 52,480 |
McKenney Charles | Director | 06/09/2014 | 315,005 |
Myszkowski Kenneth Allen | CFO | 02/12/2014 | 32,160 |
Myszkowski Kenneth Allen | CFO | 02/12/2014 | 300,290 |
FRYKMAN EDWARD W | Director | 02/07/2014 | 50,000 |
FRYKMAN EDWARD W | Director | 02/07/2014 | 50,296 |
Lewis David L. | Chief Scientific Officer | 01/02/2014 | 65,525 |
Lewis David L. | Chief Scientific Officer | 01/02/2014 | 154,292 |
McKenney Charles | Director | 10/11/2013 | 9,096 |
Anzalone Christopher Richard | President and CEO | 08/31/2010 | 8,900 |
Anzalone Christopher Richard | President and CEO | 08/27/2010 | 8,900 |
Myszkowski Kenneth Allen | CFO | 08/27/2010 | 13,350 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 13,303,757 | 0.01% | 3.62% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 2,326,876 | 0.00745% | 4.9% | Other |
ORBIMED ADVISORS LLC | 319,651 | 0.2% | -26.29% | Other |
CANDRIAM S.C.A. | 185,054 | 0.04% | -15.91% | Other |
WCM INVESTMENT MANAGEMENT, LLC | 172,865 | 0.01% | 13.56% | Growth At A Reasonable Price |
VIVO CAPITAL, LLC | 137,411 | 0.34% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 122,000 | 0.00578% | -68.02% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 97,168 | 0.12% | No change | Growth At A Reasonable Price, Value |
D. E. SHAW & CO., INC. | 45,474 | 0.00122% | New | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 29,493 | 0.01% | No change | Growth |
TUDOR INVESTMENT CORP ET AL | 10,601 | 0.00261% | New | Event Driven, Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View